nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Intracranial pressure increased—Carmustine—malignant glioma	0.0748	0.109	CcSEcCtD
Nalidixic Acid—Pefloxacin—TOP2A—malignant glioma	0.0665	0.319	CrCbGaD
Nalidixic Acid—Enoxacin—TOP2A—malignant glioma	0.0622	0.298	CrCbGaD
Nalidixic Acid—Lomefloxacin—TOP2A—malignant glioma	0.0471	0.226	CrCbGaD
Nalidixic Acid—Cholestasis—Temozolomide—malignant glioma	0.0398	0.0579	CcSEcCtD
Nalidixic Acid—Norfloxacin—TOP2A—malignant glioma	0.0327	0.157	CrCbGaD
Nalidixic Acid—Swelling—Carmustine—malignant glioma	0.0257	0.0374	CcSEcCtD
Nalidixic Acid—Injury—Carmustine—malignant glioma	0.0247	0.0359	CcSEcCtD
Nalidixic Acid—Diplopia—Carmustine—malignant glioma	0.0227	0.033	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—ASMT—malignant glioma	0.0224	0.214	CbGpPWpGaD
Nalidixic Acid—Diplopia—Temozolomide—malignant glioma	0.0219	0.0319	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Temozolomide—malignant glioma	0.0173	0.0252	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Carmustine—malignant glioma	0.0171	0.0249	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0167	0.0244	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Temozolomide—malignant glioma	0.0166	0.0241	CcSEcCtD
Nalidixic Acid—Visual impairment—Carmustine—malignant glioma	0.0151	0.022	CcSEcCtD
Nalidixic Acid—Visual impairment—Temozolomide—malignant glioma	0.0146	0.0213	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Temozolomide—malignant glioma	0.0143	0.0209	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP2C18—malignant glioma	0.0138	0.132	CbGpPWpGaD
Nalidixic Acid—Erythema—Carmustine—malignant glioma	0.0137	0.0199	CcSEcCtD
Nalidixic Acid—Erythema—Temozolomide—malignant glioma	0.0132	0.0192	CcSEcCtD
Nalidixic Acid—TDO2—Monoamine Transport—SLC6A3—malignant glioma	0.0122	0.117	CbGpPWpGaD
Nalidixic Acid—Leukopenia—Carmustine—malignant glioma	0.0122	0.0178	CcSEcCtD
Nalidixic Acid—Angioedema—Temozolomide—malignant glioma	0.0121	0.0176	CcSEcCtD
Nalidixic Acid—Vertigo—Temozolomide—malignant glioma	0.0119	0.0173	CcSEcCtD
Nalidixic Acid—Convulsion—Carmustine—malignant glioma	0.0118	0.0172	CcSEcCtD
Nalidixic Acid—Leukopenia—Temozolomide—malignant glioma	0.0118	0.0172	CcSEcCtD
Nalidixic Acid—Convulsion—Temozolomide—malignant glioma	0.0114	0.0166	CcSEcCtD
Nalidixic Acid—Arthralgia—Temozolomide—malignant glioma	0.0112	0.0164	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Carmustine—malignant glioma	0.0109	0.0159	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Temozolomide—malignant glioma	0.0108	0.0157	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Temozolomide—malignant glioma	0.0105	0.0154	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0102	0.0148	CcSEcCtD
Nalidixic Acid—Paraesthesia—Carmustine—malignant glioma	0.01	0.0146	CcSEcCtD
Nalidixic Acid—Somnolence—Carmustine—malignant glioma	0.00991	0.0144	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00981	0.0143	CcSEcCtD
Nalidixic Acid—Paraesthesia—Temozolomide—malignant glioma	0.00967	0.0141	CcSEcCtD
Nalidixic Acid—Somnolence—Temozolomide—malignant glioma	0.00958	0.0139	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Carmustine—malignant glioma	0.00911	0.0133	CcSEcCtD
Nalidixic Acid—Abdominal pain—Carmustine—malignant glioma	0.00881	0.0128	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Temozolomide—malignant glioma	0.00881	0.0128	CcSEcCtD
Nalidixic Acid—Urticaria—Temozolomide—malignant glioma	0.00856	0.0125	CcSEcCtD
Nalidixic Acid—Abdominal pain—Temozolomide—malignant glioma	0.00852	0.0124	CcSEcCtD
Nalidixic Acid—Asthenia—Carmustine—malignant glioma	0.008	0.0116	CcSEcCtD
Nalidixic Acid—Asthenia—Temozolomide—malignant glioma	0.00773	0.0112	CcSEcCtD
Nalidixic Acid—Diarrhoea—Carmustine—malignant glioma	0.00763	0.0111	CcSEcCtD
Nalidixic Acid—Pruritus—Temozolomide—malignant glioma	0.00762	0.0111	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—CAT—malignant glioma	0.00754	0.072	CbGpPWpGaD
Nalidixic Acid—Dizziness—Carmustine—malignant glioma	0.00737	0.0107	CcSEcCtD
Nalidixic Acid—Diarrhoea—Temozolomide—malignant glioma	0.00737	0.0107	CcSEcCtD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—ASMT—malignant glioma	0.00725	0.0693	CbGpPWpGaD
Nalidixic Acid—Dizziness—Temozolomide—malignant glioma	0.00712	0.0104	CcSEcCtD
Nalidixic Acid—Vomiting—Carmustine—malignant glioma	0.00709	0.0103	CcSEcCtD
Nalidixic Acid—Rash—Carmustine—malignant glioma	0.00703	0.0102	CcSEcCtD
Nalidixic Acid—Dermatitis—Carmustine—malignant glioma	0.00702	0.0102	CcSEcCtD
Nalidixic Acid—Headache—Carmustine—malignant glioma	0.00698	0.0102	CcSEcCtD
Nalidixic Acid—Vomiting—Temozolomide—malignant glioma	0.00685	0.00997	CcSEcCtD
Nalidixic Acid—Rash—Temozolomide—malignant glioma	0.00679	0.00989	CcSEcCtD
Nalidixic Acid—Dermatitis—Temozolomide—malignant glioma	0.00679	0.00988	CcSEcCtD
Nalidixic Acid—Headache—Temozolomide—malignant glioma	0.00675	0.00982	CcSEcCtD
Nalidixic Acid—Nausea—Carmustine—malignant glioma	0.00662	0.00964	CcSEcCtD
Nalidixic Acid—Nausea—Temozolomide—malignant glioma	0.0064	0.00931	CcSEcCtD
Nalidixic Acid—TDO2—Monoamine Transport—IL1B—malignant glioma	0.00499	0.0477	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—MDM2—malignant glioma	0.00416	0.0398	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—TNF—malignant glioma	0.00362	0.0346	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—SLC5A5—malignant glioma	0.00312	0.0298	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—RTEL1—malignant glioma	0.00273	0.0261	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—COX8A—malignant glioma	0.00157	0.015	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00136	0.013	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00134	0.0128	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ASMT—malignant glioma	0.00133	0.0127	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—BCAN—malignant glioma	0.00125	0.012	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—IDH2—malignant glioma	0.00101	0.00965	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP2B6—malignant glioma	0.000949	0.00907	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000889	0.00849	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—IDH1—malignant glioma	0.000868	0.0083	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SPHK1—malignant glioma	0.00084	0.00803	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP2C18—malignant glioma	0.000823	0.00786	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000813	0.00776	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00071	0.00679	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.000691	0.0066	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTT1—malignant glioma	0.000666	0.00636	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000639	0.00611	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS1—malignant glioma	0.000624	0.00596	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000608	0.00581	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—BCHE—malignant glioma	0.00058	0.00554	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC5A5—malignant glioma	0.000573	0.00547	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTP1—malignant glioma	0.000461	0.00441	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CAT—malignant glioma	0.000449	0.00429	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NCOR1—malignant glioma	0.000424	0.00405	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000354	0.00338	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CAV1—malignant glioma	0.000346	0.0033	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000325	0.0031	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CG—malignant glioma	0.000315	0.00301	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000309	0.00295	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPARG—malignant glioma	0.000304	0.0029	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CD—malignant glioma	0.000277	0.00264	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CB—malignant glioma	0.000241	0.0023	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS2—malignant glioma	0.000239	0.00228	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTEN—malignant glioma	0.000208	0.00199	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CA—malignant glioma	0.000147	0.00141	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00014	0.00134	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AKT1—malignant glioma	0.00012	0.00115	CbGpPWpGaD
